Sen. Margaret Wood Hassan

Customs Trade Partnership Against Terrorism Pilot Program Act of 2021 or the CTPAT Pilot Program Act of 2021 This bill requires the Department of Homeland Security to carry out a pilot program that assesses whether allowing certain entities to participate in the Customs Trade Partnership Against Terrorism (CTPAT) would enhance port security, combat terrorism, prevent supply chain security breaches, or otherwise meet the goals of CTPAT. Such entities are (1) non-asset-based third-party logistics providers that arrange international freight transportation and are licensed by the Department of Transportation; or (2) asset-based third-party logistics providers that facilitate cross-border activity, are licensed or bonded by specified federal agencies, and execute logistics services using their own warehousing assets and resources. The bill requires the Government Accountability Office to report on the effectiveness of CTPAT.

This resolution expresses support for the rights, freedoms, and equal treatment of lesbian, gay, bisexual, transgender, and queer (LGBTQ) individuals. The resolution r ecognizes that LGBTQ rights are human rights and protected by the laws of the United States and international treaties. Additionally, the resolution encourages the celebration of LGBTQ Pride Month in June.

Affordability is Access Act This bill establishes several requirements relating to health insurance coverage of, and access to, over-the-counter contraceptives. Specifically, the bill requires the Department of Health and Human Services, the Department of Labor, and the Department of the Treasury to specify that private health insurance plans must cover over-the-counter contraceptives that are approved by the Food and Drug Administration (FDA), even without a prescription. Under current law, private health insurance plans (with some exceptions) must cover FDA-approved prescription contraceptives, without cost-sharing requirements. The bill also prohibits retailers from interfering with an individual's access to oral contraceptives that are meant for routine, daily use and are FDA-approved for use without a prescription.

Increasing Transparency in Generic Drug Applications Act This bill requires the Food and Drug Administration to inform generic drug applicants, upon request or during review, whether the drug is qualitatively and quantitatively the same as the listed brand-name drug (and if not, the reasons why).

Biologics Market Transparency Act of 2022 This bill requires biologics manufacturers to notify the Food and Drug Administration in advance of withdrawing a product from sale.

Substance Use Prevention, Treatment, and Recovery Act This bill reauthorizes through FY2027 and modifies the Substance Abuse Prevention and Treatment Block Grant, which supports state, tribal, and territorial efforts to prevent and treat substance use disorders. Among other changes, the bill requires grant recipients to expend a portion of the grant on recovery support services. Additionally, the Substance Abuse and Mental Health Services Administration must conduct a study to develop a model needs assessment process for grant recipients to use when determining the allocation of grant funding among prevention, treatment, and recovery support activities. The bill also revises multiple provisions to eliminate stigmatizing terms (e.g., substance abuse) and otherwise align with current legislative drafting conventions.

Interchangeable Biologics Clarity Act This bill provides a statutory definition for first interchangeable biosimilar biological product and makes other technical changes with respect to the provisions that establish the corresponding periods of market exclusivity.

Elimination of the VA Asset and Infrastructure Review (AIR) Commission Act of 2022 This bill repeals the VA Asset and Infrastructure Review Act of 2018, which established the independent Asset and Infrastructure Review Commission and prescribes directives related to the development and assessment of recommendations for modernizing or realigning Veterans Health Administration facilities.

Federal Secure Cloud Improvement and Jobs Act of 2021 This bill provides statutory authority for the Federal Risk and Authorization Management Program (FedRAMP) within the General Services Administration (GSA). FedRAMP is a government-wide program that provides a standardized, reusable approach to security assessment and authorization for cloud computing products and services that process unclassified information used by agencies. The bill establishes a FedRAMP Board to provide input and recommendations to the GSA regarding the requirements and guidelines for, and the prioritization of, security assessments of cloud computing products and services. The GSA may determine whether FedRAMP may use an independent assessment service to analyze, validate, and attest to the quality and compliance of security assessment materials that pertain to cloud computing products and services. An independent assessment service that performs such work must annually report to GSA about any foreign interest in, influence of, or control of its service. The Government Accountability Office must publish a report that, among other requirements, includes an assessment of the costs incurred by agencies and cloud service providers related to the issuance of FedRAMP authorizations. The bill establishes the Federal Secure Cloud Advisory Committee.

Deepfake Task Force Act This bill requires the Department of Homeland Security to coordinate with the White House Office of Science and Technology Policy to temporarily establish the National Deepfake Provenance Task Force. Comprised of federal and nonfederal stakeholders, the task force must address threats posed by digital content forgeries (i.e., digital audio, images, and text fabricated or manipulated using artificial intelligence, machine learning, and other emerging technologies with the intent to mislead). The task force's activities include developing a plan to reduce the proliferation of digital content forgeries. The task force terminates 90 days after submitting its final report.